Finch Therapeutics Group, Inc. (FNCHQ) — key financial figures for fiscal year 2023 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2023)

$107.0K

Net Income/Loss (FY2023)

-$74.8M

Total Assets (FY2023)

$55.4M

Total Equity (FY2023)

$22.9M

Cash Flows from Operating Activities (FY2023)

-$31.5M

Source: Finch Therapeutics Group, Inc. 10-K filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.